A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors

被引：0
|
作者：
Autumn J. McRee
Janine M. Davies
Hanna G. Sanoff
Richard M. Goldberg
Stephen Bernard
E. Claire Dees
Kimberly Keller
Anastasia Ivanova
Bert H. O’Neil
机构：
[1] The University of North Carolina at Chapel Hill,Department of Medicine, Division of Hematology/Oncology, School of Medicine
[2] BC Cancer Agency,School of Medicine
[3] The Ohio State University,School of Medicine
[4] Indiana University,Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 74卷
关键词：
Everolimus; 5-Fluorouracil; Oxaliplatin; Panitumumab; Metastatic colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：117 / 123
页数：6
相关论文
共 50 条
  • [41] Results of a phase I study of andecaliximab in combination with mFOLFOX6 and bevacizumab in patients with previously untreated metastatic colorectal cancer
    Lenz, H-J.
    Park, H.
    Shah, M. A.
    Berlin, J. D.
    Bruetman, D.
    Chaves, J.
    Gordon, M.
    Patel, R.
    Starodub, A.
    Liu, J.
    Brachmann, C. Baker
    Bhargava, P.
    Wainberg, Z. A.
    Bendell, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [42] MFOLFOX6 plus CEDIRANIB VS MFOLFOX6 plus BEVACIZUMAB IN PREVIOUSLY UNTREATED METASTATIC COLORECTAL CANCER (MCRC): A RANDOMIZED, DOUBLE-BLIND, PHASE II/III STUDY (HORIZON III)
    Schmoll, H.
    Cunningham, D.
    Sobrero, A.
    Karapetis, C.
    Rougier, P.
    Koski, S. L.
    Barker, P.
    Mookerjee, B.
    Robertson, J.
    van Cutsem, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 189 - 189
  • [43] SUNITINIB PLUS 5-FLUOROURACIL, LEUCOVORIN AND OXALIPLATIN (MFOLFOX6) VS. BEVACIZUMAB PLUS MFOLFOX6 IN FRST-LINE METASTATIC COLORECTAL CANCER (MCRC) - INTERIM RESULTS OF A RANDOMIZED, PHASE IIB STUDY
    Hecht, J.
    Yoshino, T.
    Mitchell, E.
    Dees, M.
    Kroening, H.
    Patel, R.
    Welslau, M.
    Dakhil, S.
    Yamazaki, K.
    Maneval, Chow E.
    Kretzschmar, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 15 - 15
  • [44] PHASE II TRIAL OF mFOLFOX6/CapeOX PLUS BEVACIZUMAB WITH OXALIPLATIN IN A STOP AND GO FASHION IN ADVANCED mCRC
    Gamoh, M.
    Shimodaira, H.
    Murakawa, Y.
    Kato, S.
    Amagai, K.
    Isoge, H.
    Niitani, T.
    Itoh, J.
    Yoshioka, T.
    Ishioka, C.
    ANNALS OF ONCOLOGY, 2013, 24
  • [45] Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for RAS Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial
    Tang, Wentao
    Ren, Li
    Liu, Tianshu
    Ye, Qinghai
    Wei, Ye
    He, Guodong
    Lin, Qi
    Wang, Xiaoying
    Wang, Mingliang
    Liang, Fei
    Cui, Yuehong
    Xu, Jianmin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (27) : 3175 - +
  • [46] A phase II study of mFOLFOX6 plus nivolumab as initial therapy for patients with advanced esophageal squamouscell cancer: FLONTALE trial
    Kubota, Y.
    Ueyama, S.
    Yamamoto, Y.
    Amanuma, Y.
    Furuta, M.
    Sato, S.
    Tsushima, T.
    Moriwaki, T.
    Tanabe, K.
    Sunakawa, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S196 - S196
  • [47] Cediranib in combination with mFOLFOX6: results from the cohort expansion phase of a two-part Phase I study
    LoRusso, P.
    Zalupski, M.
    Desai, S.
    Burris, H. A.
    Stella, P. J.
    Xu, J.
    Liu, Q.
    Mookerjee, B.
    Shields, A. F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 133 - 133
  • [48] Impact of sex on the efficacy of first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus Y90-radioembolization in patients with metastatic colorectal cancer: An exploratory, retrospective analysis of the phase III SIRFLOX trial
    Heinrich, Kathrin
    Heinemann, Volker
    Westphalen, Benedikt
    Oecal, Osman
    Van Hazel, Guy A.
    Gibbs, Peter
    Seidensticker, Max
    Ricke, Jens
    Seidensticker, Ricarda
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] COMBINATION THERAPY WITH LINIFANIB (ABT-869) AND MFOLFOX6 FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
    O'Neil, B.
    Karapetis, C.
    Goff, L.
    Gupta, N.
    Qin, Q.
    Pradhan, R.
    Ricker, J.
    Mckee, M.
    Carlson, D.
    Goldberg, R.
    Berlin, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 79 - 79
  • [50] A PHASE II STUDY OF CEDIRANIB IN COMBINATION WITH MFOLFOX6 IN JAPANESE PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (CRC)
    Muro, K.
    Kato, T.
    Yamaguchi, K.
    Bando, H.
    Hazama, S.
    Amagi, K.
    Baba, H.
    Denda, T.
    Sakamoto, J.
    Mishima, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 199 - 199
12345